Hepatitis B vaccine route and dose in adults
Reading File
Finding Sources
Searching the Web
Hepatitis B vaccine adult dose route schedule 2024 CDC guidelines
Reading File
Reading File
Here is a complete, textbook-referenced summary of Hepatitis B vaccine dosing and administration in adults:
Hepatitis B Vaccine in Adults
Route
Intramuscular (IM) injection into the deltoid muscle.
- The deltoid is preferred over the gluteal site because gluteal injection often deposits vaccine into fat rather than muscle, resulting in lower seroconversion rates.
- Intradermal administration is not recommended - the immune response is less reliable, particularly in children.
Standard Adult Dose and Schedule
| Vaccine | Dose | Volume | Schedule |
|---|---|---|---|
| Engerix-B (recombinant) | 20 mcg | 1 mL | 0, 1, 6 months |
| Recombivax HB (recombinant) | 10 mcg | 1 mL | 0, 1, 6 months |
| Heplisav-B (newer, 2-dose) | 25 mcg | 0.5 mL | 0, 1 month (only 2 doses) |
| Twinrix (HepA + HepB combined) | 20 mcg HepB | 1 mL | 0, 1, 6 months (or 0, 7 days, 21-30 days + booster at 12 months) |
WHO / Park's Preventive Medicine: "The dose for adults is 10-20 micrograms initially (depending on the formulation) and again at 1 and 6 months." - Park's Textbook of Preventive and Social Medicine
Special Populations
| Population | Dose Adjustment |
|---|---|
| Hemodialysis / immunocompromised | 40 mcg (double dose) - Recombivax HB 40 mcg/mL formulation or Engerix-B 40 mcg (two 1 mL doses at separate sites) |
| Adults >40 years | Response rate drops below 90%; consider post-vaccination serology |
| Adults >60 years | Only 65-75% achieve protective antibody levels; consider checking anti-HBs titers |
| Premature infants <2000 g | Delay birth dose - better response by 1 month of chronological age |
Key Points
- Minimum interval between doses: 4 weeks. Longer intervals increase anti-HBs titres but not seroconversion rates.
- Protective response: >95% in infants, children, and young adults after complete series.
- Duration of protection: At least 15 years; current evidence supports lifelong protection.
- Interchangeability: All internationally marketed HepB vaccines are considered immunologically comparable and can be used interchangeably.
- Booster doses: Not routinely recommended for immunocompetent adults after a complete primary series.
- Post-vaccination serology: Anti-HBs titer ≥10 mIU/mL is considered protective.
- Hepatitis B vaccine does not interfere with other vaccines and can be co-administered.
Post-Exposure Prophylaxis (adults, unvaccinated)
For percutaneous or mucosal exposure to HBsAg-positive source:
- HBIG x1 (given as soon as possible)
- Initiate hepatitis B vaccination series (0, 1, 6 months)
- Rosen's Emergency Medicine; Park's Textbook of Preventive and Social Medicine; Washington Manual of Medical Therapeutics
This is a shared conversation. Sign in to Orris to start your own chat.